ArticleProceedings of the National Academy of Sciences of the United States of America2009

An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells.

Shahir S Rizk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.